Cognition Therapeutics (CGTX) SEC Filings: History & Chart

Cognition Therapeutics, Inc.(CGTX)

Biotechnology · Purchase, NY

$0.94+0.01 (+1.41%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders. Its most advanced experimental therapy is CT1812, which acts as a sigma-2 receptor antagonist. This compound is currently being evaluated in Phase II clinical trials for the management of mild-to-moderate Alzheimer's disease and dementia with Lewy bodies (DLB). Additionally, it has successfully concluded Phase I trials for early-stage Alzheimer's and is undergoing preclinical investigation for dry age-related macular degeneration (AMD). The company's pipeline also includes CT2168, a treatment candidate for synucleinopathies—a category of diseases encompassing DLB and Parkinson's disease—and CT2074, which is in development for dry AMD. Cognition Therapeutics, Inc. was established in 2007 and operates from its headquarters in Purchase, New York.

Purchase, NY

14 employees

www.cogrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Lisa Ricciardi

View full financials

Form	Filing Date	Accepted	Document
10-Q	Aug 7, 2026	Aug 7, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Jun 24, 2026	Jun 24, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
8-K	Jun 18, 2026	Jun 18, 2026	View filing
8-K	Jun 4, 2026	Jun 4, 2026	View filing
8-K	May 21, 2026	May 21, 2026	View filing
10-Q	May 8, 2026	May 8, 2026	View filing
8-K	May 7, 2026	May 7, 2026	View filing
4	May 4, 2026	May 4, 2026	View filing
ARS	Apr 27, 2026	Apr 27, 2026	View filing
DEFA14A	Apr 27, 2026	Apr 27, 2026	View filing
DEF 14A	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 20, 2026	Apr 20, 2026	View filing
4	Apr 20, 2026	Apr 20, 2026	View filing
4	Apr 20, 2026	Apr 20, 2026	View filing
S-8	Mar 26, 2026	Mar 26, 2026	View filing
10-K	Mar 26, 2026	Mar 26, 2026	View filing
8-K	Mar 26, 2026	Mar 26, 2026	View filing
8-K	Mar 2, 2026	Mar 2, 2026	View filing
4	Feb 18, 2026	Feb 18, 2026	View filing
4	Feb 18, 2026	Feb 18, 2026	View filing
4	Feb 18, 2026	Feb 18, 2026	View filing
4	Feb 5, 2026	Feb 5, 2026	View filing
4	Feb 5, 2026	Feb 5, 2026	View filing
4	Feb 5, 2026	Feb 5, 2026	View filing

SEC Filings

Recent Filings